Sakar Healthcare Limited (SAKAR.NS)
NSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹989.00 (+6.31%) as of
Key statistics
- Market cap
- 21.71B
- P/E (TTM)
- 71.93
- Forward P/E
- 24.18
- EPS (TTM)
- 13.75
- Dividend yield
- 0.00%
- 52-week range
- 352.05 – 1,229.85
- Beta
- 0.41
- Revenue (TTM)
- 3.03B
- Profit margin
- 14.16%
- Analyst target
- ₹1,020.00
- Volume
- 289.60k
About Sakar Healthcare Limited
Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company offers general and oncology products in various forms, such as liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. It also exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Ahmedabad, India
- Employees
- 435
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- Nuvama Wealth Management Limit (NUVAMA.BO)
- 63 Moons Technologies Limited (63MOONS.BO)
- THEJO ENGINEERING LIMITED (THEJO.NS)
- ESPRIT STONES LIMITED (ESPRIT-SM.NS)
- CHOICE INTERNATIONAL LTD. (CHOICEIN.BO)
- VILAS TRANSCORE LIMITED (VILAS-SM.NS)
- NUCLEUS SOFTWARE EXPORTS (NUCLEUS.NS)
- Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)